Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0152294 METHOD FOR EXTRACTING SOLUBLE PROTEINS FROM MICROALGAL BIOMASS
Method for preparing a protein isolate of the biomass of microalgae of the genus Chlorella, includes: supplying a microalgal biomass produced by fermentation;...
2017/0152293 RECOMBINANT CYTOTOXIN AND USE THEREOF
A recombinant cytotoxin is provided. The recombinant cytotoxin of the present invention comprises a cytotoxin, a cell penetrating peptide (CPP), and...
2017/0152292 RESPIRATORY SYNCYTIAL VIRUS (RSV) REPLICATION INHIBITORS
The invention provides polypeptides interacting with the binding of the RSV phosphoprotein P with the RSV nucleoprotein N and methods of using such...
2017/0152291 N- (HYDROPHOBE-SUBSTITUTED) VANCOSAMINYL [PSI-[C(=NH) NH] TPG4] VANCOMYCIN AND [PSI-[CH2NH]TPG4] VANCOMYCIN
The total synthesis and evaluation of key analogs of vancomycin containing single atom changes in the binding pocket are disclosed as well as their...
2017/0152290 BETA HAIRPIN PEPTIDES HAVING ANTIVIRAL PROPERTIES AGAINST DENGUE VIRUS
The present invention discloses structurally constrained synthetic peptides that have been optimized for the formation of a beta hairpin structure. Said...
2017/0152289 PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE
The invention relates to a process for solution-phase synthesis of D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide, an active ingredient used for...
2017/0152288 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
The present invention relates to the use for affinity purification of an antibody or a fragment of an antibody, of a ligand-substituted matrix comprising a...
2017/0152287 METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS
Methods and compositions are provided for covalently linking a chemical species to a recombinant or synthetic polypeptide. The methods involve the reaction of...
2017/0152286 STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS
The present disclosure relates to the design and generation of stapled helical peptides that perturb protein-protein interactions (PPIs). The methods disclosed...
2017/0152285 EXTRACTING METHOD OF KUGUACIN, PHARMACEUTICAL COMPOSITION COMPRISING THE KUGUACIN AND USE THEREOF
The present invention is related to an extracting method of kuguacin, pharmaceutical composition comprising the kuguacin and use thereof, specifically related...
2017/0152284 NEUROACTIVE 19-ALKOXY-17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT...
The present disclosure is generally directed to neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids as referenced herein, and pharmaceutically...
2017/0152283 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE
Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R.sup.1, R.sup.2, R.sup.4, X, Y, Z, m, and n are as defined herein,...
2017/0152282 NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts...
2017/0152281 Crystalline solvate forms of a pharmaceutical
The invention provides and describes solid state 17.alpha.-ethynyl-androst-5-ene-3.beta.,7.beta.,17.beta.-triol including amorphous and crystalline forms and...
2017/0152280 SCAPHOPETALONE ANALOGS AND THEIR USES
The present disclosure relates to scaphopetalone analogs, methods of making the analogs, and their uses.
2017/0152279 Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1
The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes...
2017/0152278 Depolymerisation Of Lignin In Biomass
A method of obtaining depolymerized lignin from biomass using a transition metal catalyst and a solvent mixture of organic solvent and water. The invention...
2017/0152277 METHODS OF FORMING THIN FILM AND FABRICATING INTEGRATED CIRCUIT DEVICE USING NIOBIUM COMPOUND
Disclosed herein is a method of forming a thin film. The method includes forming a niobium-containing film by using a niobium precursor composition and a...
2017/0152276 NOVEL SALT OF TENOFOVIR DISOPROXIL
Disclosed is a novel tenofovir disoproxil edisylate salt having the structure of Chemical Formula 1.
2017/0152275 5'-DIBENZYL PHOSPHATES OF 5-AZACYTIDINE OR 2'-DEOXY-5-AZACYTIDINE
The present invention relates to a novel compound represented by formula (1), or salt thereof, ##STR00001## wherein R is hydroxy group or hydrogen atom; R.sup.1...
2017/0152274 CHARGED LINKERS AND THEIR USES FOR CONJUGATION
Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.
2017/0152273 Topical Pharmaceutical Formulations For Treating Inflammatory-Related Conditions
Topical pharmaceutical formulations, and methods of treating inflammatory conditions with these formulations, are disclosed.
2017/0152272 LOW PH SYSNTHESIS OF ZINC-LYSINE COMPLEX
The disclosure provides an improved synthesis for a zinc-lysine complex having the formula [Zn(C.sub.6H.sub.14N.sub.2O.sub.2).sub.2Cl].sup.+Cl .sup.-, in which...
2017/0152271 GAK MODULATORS AS ANTIVIRALS
The present invention relates to the use of a class of novel isothiazolo[4,3-b]pyridine derivatives as well as to pharmaceutical compositions comprising one or...
2017/0152270 METHOD FOR PRODUCING PYRIDINE COMPOUND
A pyridine compound represented by formula (1) that is useful as an insecticide is produced by reacting a compound represented by formula (2) and a compound...
2017/0152269 FUSED BICYCLIC COMPOUNDS AND THEIR USE AS CDK INHIBITORS
The present invention provides a fused bicyclic compound according to formula (H) or a pharmaceutically acceptable salt thereof, wherein L is --S-- or --O--; M...
2017/0152268 NOVEL INDENE DERIVATIVE, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR...
The present invention relates to a novel indene derivative, a preparation method for the same, and a pharmaceutical composition for preventing or treating...
2017/0152267 BENZOPYRYLIUM COMPOUNDS
Compounds used as labels with properties comparable to known fluorescent compounds. The compounds are conjugated to proteins and nucleic acids for biological...
2017/0152266 Novel Alpha-Hydroxy Carboxylic Acid and Derivatives and Other GRAS Based Prodrugs of Oxycodone and Uses thereof
The invention describes pharmaceutical compounds and compositions comprised of a ligand attached to the opioid oxycodone, in a manner that substantially...
2017/0152265 IMIDAZOTRIAZINONE COMPOUNDS
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes,...
2017/0152264 AMINOPYRIDAZINONE COMPOUNDS AS PROTEIN KINASE INHIBITORS
The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and...
2017/0152263 Substituted Indazole Compounds as IRAK4 Inhibitors
The present invention provides substituted indazole compound of formula (I) and pharmaceutically acceptable salts thereof, and their use to inhibit IRAK4...
2017/0152262 VINYLOGOUS THIOESTER COMPOUNDS AND METHODS OF USE
Provided herein are vinylogous thioester compounds and methods for using the compounds.
2017/0152261 SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES
The invention provides a series of bioactive small molecules that target expanded r(CGG) repeats, termed r(CGG).sup.exp, that causes Fragile X-associated...
2017/0152260 STAT3 INHIBITOR
Provided are STAT3 inhibitors and methods of treating inflammation or a hyperproliferative disease such as, e.g., cancer. In some aspects, compounds may be...
2017/0152259 HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR
Provided is a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X is selected from a 3-9 membered carbon ring or a ring which is...
2017/0152258 Substituted Pyridopyrazines as Syk Inhibitors
The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R.sup.1,...
2017/0152257 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING...
A phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof was synthesized, which exhibits potent...
2017/0152256 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS
The invention relates to novel 3,5-dichloro,4-(3,4-(cyclo-) alkoxyphenyl)-2-carbonyloxy)ethyl)pyridine compounds which are inhibitors of the phosphodiesterase...
2017/0152255 1,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
A compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, where: Q can be 1,2,4-triazin-3-yl, pyridazin-3-yl,...
2017/0152254 1,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
A compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, where: Q can be 5-methylpyridazin-3-yl, 5-chloropyridazin-3-yl, ...
2017/0152253 Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV
A process for preparing [(1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid II, by the resolution of racemic 4-oxo-1,2-cyclopentanedicarboxylic acid (V), said...
2017/0152252 TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion
The invention discloses compounds of formula I ##STR00001## wherein Y is a group of formula A, B, C, D, or E: ##STR00002## and W, Q, n, R1, R2, R3, U1-U5, J...
2017/0152251 NOVEL CRYSTALLINE FORM OF 5-CHLORO-N-(METHYL)THIOPHENE-2-CARBOXAMIDE METHANESULFONATE AND PHARMACEUTICAL...
The present invention relates to a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-- ...
2017/0152250 INSECTICIDAL COMPOUNDS BASED ON ISOXAZOLINE DERIVATIVES
The present invention relates to compounds of formula (I): ##STR00001## wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, G.sup.1, L, Y.sup.1, Y.sup.2, Y.sup.3,...
2017/0152249 NOVEL BENZIMIDAZOLE DERIVATIVES AS KINASE INHIBITORS
The present invention relates to derivatives of benzimidazoles of formula (I) as disclosed herein as well as pharmaceutical compositions comprising said...
2017/0152248 CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS
The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using...
2017/0152247 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES
Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles,...
2017/0152246 Protein Kinase C Inhibitors and Uses Thereof
This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and...
2017/0152245 BENZIMIDAZOLE COMPOUNDS AND THEIR APPLICATION IN CARDIOVASCULAR DISEASES
The present invention provides substituted benzimidazoles, pharmaceutical composition comprising the substituted benzimidazoles, and their use for preventing...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.